175 related articles for article (PubMed ID: 6186008)
1. Radioimmunoassay of calcitonin in unextracted human serum: a sensitive method.
Emmertsen K; Marqversen J; Jensen FT; Hansen HH
Scand J Clin Lab Invest; 1982 Nov; 42(7):539-44. PubMed ID: 6186008
[TBL] [Abstract][Full Text] [Related]
2. Ghrelin in human medullary thyroid carcinomas.
Morpurgo PS; Cappiello V; Verga U; Vicentini L; Vaghi I; Lauri E; Nebuloni M; Beck-Peccoz P; Spada A
Clin Endocrinol (Oxf); 2005 Oct; 63(4):437-41. PubMed ID: 16181236
[TBL] [Abstract][Full Text] [Related]
3. Radioimmunoassay of human calcitonin in serum and tissue from healthy individuals and patients with medullary carcinoma of the thyroid gland.
Gautvik KM; Normann T; Teig V; Wille SO; Brennhovd IO; Christensen I
Scand J Clin Lab Invest; 1976 Jul; 36(4):323-9. PubMed ID: 959750
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of a radioimmunoassay for determination of calcitriol in human sera employing a 125I-labelled tracer.
Withold W; Wolff T; Degenhardt S; Reinauer H
Eur J Clin Chem Clin Biochem; 1995 Dec; 33(12):959-63. PubMed ID: 8845429
[TBL] [Abstract][Full Text] [Related]
5. Standardization and clinical application of a radioimmunoassay for human calcitonin.
Prieto S; Pérez-Gutiérrez A; Tamarit J
Rev Esp Fisiol; 1979 Mar; 35(1):21-7. PubMed ID: 461906
[TBL] [Abstract][Full Text] [Related]
6. Postoperative pentagastrin-stimulated serum calcitonin concentrations in patients with medullary thyroid carcinoma: reoperations in patients with concentrations bordering the detection limit.
Meybier H; Schmidt-Gayk H; Buhr H; Raue F
Henry Ford Hosp Med J; 1989; 37(3-4):138-40. PubMed ID: 2576947
[TBL] [Abstract][Full Text] [Related]
7. Secretory protein 7B2. A novel tumor marker of medullary carcinoma of the thyroid.
Ohashi M; Natori S; Fujio N; Iguchi H; Nawata H
Horm Metab Res; 1990 Feb; 22(2):114-6. PubMed ID: 2323727
[TBL] [Abstract][Full Text] [Related]
8. Determination of serum calcitonin by immunometric two-site assays in normal subjects and patients with medullary thyroid carcinoma.
Zink A; Blind E; Raue F
Eur J Clin Chem Clin Biochem; 1992 Dec; 30(12):831-5. PubMed ID: 1489858
[TBL] [Abstract][Full Text] [Related]
9. [The setting up of human serum calcitonin radioimmunoassay and its clinical application].
Zhan Z; Meng X; Chen L; Zhou X; Liu S
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1997 Jun; 19(3):236-40. PubMed ID: 10453498
[TBL] [Abstract][Full Text] [Related]
10. The establishment of a radioimmunoassay of calcitonin in human serum.
Kwok CF; Jap TS; Ho LT
Zhonghua Yi Xue Za Zhi (Taipei); 1989 Jan; 43(1):9-14. PubMed ID: 2766064
[TBL] [Abstract][Full Text] [Related]
11. Diagnosis of medullary carcinoma of the thyroid (MCT) by calcitonin assay using monoclonal antibodies: criteria for the pentagastrin stimulation test in hereditary MCT.
Guilloteau D; Perdrisot R; Calmettes C; Baulieu JL; Lecomte P; Kaphan G; Milhaud G; Besnard JC; Jallet P; Bigorgne JC
J Clin Endocrinol Metab; 1990 Oct; 71(4):1064-7. PubMed ID: 2401708
[TBL] [Abstract][Full Text] [Related]
12. Medullary thyroid carcinoma and calcitonin.
Emmertsen K
Dan Med Bull; 1985 Mar; 32(1):1-28. PubMed ID: 2859145
[TBL] [Abstract][Full Text] [Related]
13. Radioactive iodine treatment in medullary thyroid carcinoma.
Faik Erdogan M; Gursoy A; Erdogan G; Kamel N
Nucl Med Commun; 2006 Apr; 27(4):359-62. PubMed ID: 16531922
[TBL] [Abstract][Full Text] [Related]
14. Calcitonin measurement to detect medullary thyroid carcinoma in nodular goiter: German evidence-based consensus recommendation.
Karges W; Dralle H; Raue F; Mann K; Reiners C; Grussendorf M; Hüfner M; Niederle B; Brabant G;
Exp Clin Endocrinol Diabetes; 2004 Jan; 112(1):52-8. PubMed ID: 14758572
[TBL] [Abstract][Full Text] [Related]
15. Immuno-heterogeneity of the calcitonins of hypercalcemia, breast and lung cancers and medullary carcinoma of thyroid.
Roof BS; Weinstein R; Vujic I; Burdash NM
Biomedicine; 1979 Jun; 30(2):82-90. PubMed ID: 476268
[TBL] [Abstract][Full Text] [Related]
16. Localization and resection of clinically inapparent medullary carcinoma of the thyroid.
Norton JA; Doppman JL; Brennan MF
Surgery; 1980 Jun; 87(6):616-22. PubMed ID: 7376073
[TBL] [Abstract][Full Text] [Related]
17. [Standards, options and recommendations for blood tumor markers in thyroid cancers].
Pichon MF; Basuyau JP; Gory-Delabaere G; Eche N; Daver A; Blanc-Vincent MP; Riedinger JM; Deneux L; Bidart JM
Bull Cancer; 2001 Aug; 88(8):775-92. PubMed ID: 11578946
[TBL] [Abstract][Full Text] [Related]
18. [Usefulness of serum calcitonin, CEA and AFP assays in the early detection of medullary thyroid carcinoma relapse].
Łacka K; Michałek K; Majewski P
Wiad Lek; 2002; 55(7-8):394-403. PubMed ID: 12428567
[TBL] [Abstract][Full Text] [Related]
19. Screening for medullary thyroid carcinoma: experience with different immunoassays for human calcitonin.
Bieglmayer C; Scheuba C; Niederle B; Flores J; Vierhapper H
Wien Klin Wochenschr; 2002 Apr; 114(7):267-73. PubMed ID: 12089862
[TBL] [Abstract][Full Text] [Related]
20. Radioimmunoassay of urinary calcitonin in normal subjects and in patients with medullary carcinoma of the thyroid.
Morimoto S; Onishi T; Okada Y; Lee S; Imanaka S; Fukuo K; Kono H; Kumahara Y
Endocrinol Jpn; 1982 Feb; 29(1):1-10. PubMed ID: 7106058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]